
FDA Approves Dupixent for Urticaria in Young Children
The FDA approved Dupixent for Urticaria in children aged 2-11. Learn how this biologic treats chronic hives resistant to standard antihistamines.
Read guide ->
Common health conditions, symptoms, and treatments, including mental health, allergies, and chronic diseases.
Showing 50 articles in Everyday Health

The FDA approved Dupixent for Urticaria in children aged 2-11. Learn how this biologic treats chronic hives resistant to standard antihistamines.
Read guide ->
Learn about Ozempic vision loss risks and the link to NAION. Get the latest study results, symptoms to watch, and legal updates for 2026.
Read guide ->
Explore NAION eye risks associated with semaglutide weight loss drugs. Learn about rare symptoms, monitoring tips, and the latest safety updates.
Read guide ->
Optimize your diverticulitis diet for recovery and prevention. Discover the best foods for flare-ups, low-fiber options, and gut health tips.
Read guide ->
Relieve digital eye strain with this 2026 guide on the 20-20-20 rule, ergonomic screen placement, and effective treatments for vision comfort.
Read guide ->
Explore the Tirzepatide NAION risk link to vision loss. Learn about Mounjaro side effects, Zepbound symptoms, and required ophthalmic monitoring.
Read guide ->